凯尔奇样ECH相关蛋白-1和GRACE风险评分在非ST升高心肌梗塞中之间的关联
E Vuruskan1, G Altunbas, M Kaplan
1Department of Cardiology, Gaziantep University Education and Research Hospital, Gaziantep, Turkey. ertanvuruskan@hotmail.com.
概括
非ST升高心肌梗塞 (NSTEMI) 患者的凯尔奇样ECH相关蛋白1 (KEAP1) 水平较高,与更高的GRACE分数相关,这表明KEAP1是NSTEMI的潜在风险因素.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 凯尔奇类ECH相关蛋白1 (KEAP1) 具有抗氧化特性.
- 不完全理解KEAP1在非ST升高心肌梗塞 (NSTEMI) 中的作用.
- 评估KEAP1水平可能有助于了解心肌梗塞病理生理学.
研究的目的:
- 测量NSTEMI患者和健康对照中的KEAP1水平.
- 研究NSTEMI患者的KEAP1水平和GRACE风险得分之间的关联.
- 探索KEAP1水平和左心室喷射率 (LVEF) 之间的关系.
主要方法:
- 在78名NSTEMI患者和77名健康对照中量化KEAP1水平.
- 为所有参与者计算了GRACE风险分数和LVEF.
- 标准血液检测与KEAP1测量一起进行.
主要成果:
- 与对照组相比,NSTEMI患者的KEAP1水平显著升高 (671.1 ± 120.7与262.7 ± 105.7相比,p < 0.001).
- 在NSTEMI患者的KEAP1水平和GRACE得分之间观察到中度的正相关性 (r = +0.521,p < 0.001).
- 在KEAP1水平和LVEF之间发现了负相关性 (r = -0.264,p < 0.001).
结论:
- 升高的KEAP1水平可以作为NSTEMI的预测生物标志物.
- 更高的KEAP1可能表明NSTEMI患者的不良临床事件风险增加和预后较差.
- KEAP1值得进一步研究,因为它可能是心血管疾病的治疗标或诊断标记.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
42
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
42
Acute Coronary Syndrome I: Introduction
32
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
32
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
21
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
21
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Coronary Artery Disease II: Pathophysiology
14
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
14


